Recordings from all lectures 2025
Nordic Alzheimer’s Disease Symposium
5th – 6th September 2025
• Stockholm / Arlanda
Chapters:
Current understanding of the AD patology
Prof. Heikki Tanila
University of Eastern Finland – Koupio
Diagnostics procedures and criteria for AD
Ass. Prof. Niklas Mattsson-Carlgren
Lund University and University Hospital Lund
Epidemiology of AD
Prof. Ingmar Skoog
University of Gothenburg
Fluid biomarkers
Prof. Henrik Zetterberg
Clinical Neurochemistry laboratory –
Sahlgrenska University Hospital
Imaging in AD
Adj. professor Tobias Granberg
Karolinska University Hospital
Panel discussion: Early diagnosis and biomarkers in AD - Nordic country perspectives
Finland: Johanna Krüger & Eino Solje
Denmark: Kristian Steen-Frederiksen
Norway: Tormod Fladby
Sweden: Henrik Zetterberg
Alzheimer’s disease - Non-pharmacological interventions
Prof. Miia Kivipelto
Karolinska Institute and
Karolinska University Hospital
Anti-amyloid antibodies - clinical efficacy and safety data overview
Ass. Prof. Eino Solje
Koupio University Hospital &
University of Eastern Finland
Future drug candidates for AD therapy
Ass. Prof. Kristian Steen-Frederiksen
Danish Dementia Research Center –
Rikshospitalet
Clinical experience with anti-amyloid treatments in the US
Marwan Noel Sabbagh
MD, FAAN,
Department of Neurology
Barrow Neurological Institute
Cognitive and functional assessments and digital opportunities
Hanneke Rhodius-Meester
Senior Phycisian/MD/PhD,
Oslo University Hospital/
Alzheimer Center Amsterdam
Understanding ARIA
Ass. Professor Tiago Gil Oliveira
Hospitals de Braga
Alzheimer costs and impact of DMTs for the society?
Prof. Linus Jönsson
MD, PhD, Health Economics
Department of Neurobiology,
Care Sciences and Society
SveDem and the new module for new medical treatments of Alzheimer’s disease
Prof. Maria Eriksdotter
Karolinska Institute &
Karolinska University Hospital
